[{"NetIncomeLoss_1_Q1_USD":8650000.0,"AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax_0_Q1_USD":34000.0,"InventoryFinishedGoodsNetOfReserves_0_Q1_USD":1154000.0,"AccumulatedOtherComprehensiveIncomeLossNetOfTax_0_Q1_USD":192000.0,"NetCashProvidedByUsedInInvestingActivities_1_Q1_USD":71000.0,"Depreciation_1_Q1_USD":345000.0,"AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_0_Q1_USD":7000.0,"IncomeTaxReconciliationOtherReconcilingItems_1_Q1_USD":-300000.0,"OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax_1_Q1_USD":1000.0,"AccountsPayableAndAccruedLiabilitiesCurrent_0_Q1_USD":26105000.0,"AssetsCurrent_0_Q1_USD":421224000.0,"AccountsPayableAndOtherAccruedLiabilitiesCurrent_0_Q1_USD":1803000.0,"OtherNoncashIncomeExpense_1_Q1_USD":-295000.0,"PaymentsToAcquireAvailableForSaleSecuritiesDebt_1_Q1_USD":93060000.0,"SellingGeneralAndAdministrativeExpense_1_Q1_USD":29797000.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_1_Q1_shares":2137110.0,"StockIssuedDuringPeriodValueShareBasedCompensation_1_Q1_USD":1849000.0,"ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities_1_Q1_USD":93261000.0,"CommonStockSharesIssued_0_Q1_shares":55560214.0,"InventoryWorkInProcessNetOfReserves_0_Q1_USD":207000.0,"AvailableForSaleSecuritiesDebtSecurities_0_Q1_USD":306030000.0,"Assets_0_Q1_USD":543191000.0,"CommitmentsAndContingencies_0_Q1_USD":null,"OtherComprehensiveIncomeLossNetOfTax_1_Q1_USD":-47000.0,"AccruedRoyaltiesCurrent_0_Q1_USD":5318000.0,"Liabilities_0_Q1_USD":75564000.0,"ResearchAndDevelopmentExpense_1_Q1_USD":16131000.0,"EarningsPerShareBasic_1_Q1_USD":0.16,"EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_1_Q1_USD":-15000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q1_shares":56505087.0,"AssetsFairValueDisclosure_0_Q1_USD":306030000.0,"AccountsReceivableNetCurrent_0_Q1_USD":31474000.0,"IncomeTaxExpenseBenefit_1_Q1_USD":1778000.0,"InvestmentIncomeNetAmortizationOfDiscountAndPremium_1_Q1_USD":-490000.0,"CommonStockValue_0_Q1_USD":56000.0,"Revenues_1_Q1_USD":62669000.0,"IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_1_Q1_USD":-5272000.0,"NetCashProvidedByUsedInFinancingActivities_1_Q1_USD":1849000.0,"CostsAndExpenses_1_Q1_USD":52328000.0,"IncreaseDecreaseInInventories_1_Q1_USD":-42000.0,"DebtSecuritiesAvailableForSaleRealizedGainLoss_1_Q1_USD":12000.0,"ComprehensiveIncomeNetOfTax_1_Q1_USD":8603000.0,"AmortizationOfIntangibleAssets_1_Q1_USD":370000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_1_Q1_pure":0.0073,"CashAndCashEquivalentsAtCarryingValue_0_Q1_USD":72132000.0,"OperatingLeaseLiabilityNoncurrent_0_Q1_USD":11125000.0,"AdditionalPaidInCapitalCommonStock_0_Q1_USD":656057000.0,"PreferredStockSharesOutstanding_0_Q1_shares":0.0,"CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization_1_Q1_USD":6030000.0,"ShareBasedCompensation_1_Q1_USD":3909000.0,"PreferredStockParOrStatedValuePerShare_0_Q1_USD":0.001,"RetainedEarningsAccumulatedDeficit_0_Q1_USD":-188678000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_1_Q1_USD":11098000.0,"IncreaseDecreaseInAccountsReceivable_1_Q1_USD":1483000.0,"CommonStockSharesOutstanding_0_Q1_shares":55560214.0,"EarningsPerShareDiluted_1_Q1_USD":0.15,"AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_0_Q1_USD":213000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1_Q1_USD":3909000.0,"NetCashProvidedByUsedInOperatingActivities_1_Q1_USD":9193000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q1_shares":55145789.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsWeightedAverageVolatilityRate_1_Q1_pure":0.46,"LiabilitiesCurrent_0_Q1_USD":61784000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0_Q1_USD":72711000.0,"PrepaidExpenseAndOtherAssetsCurrent_0_Q1_USD":10227000.0,"ProceedsFromStockOptionsExercised_1_Q1_USD":1849000.0,"WeightedAverageNumberDilutedSharesOutstandingAdjustment_1_Q1_shares":1359298.0,"AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_0_Q1_USD":158000.0,"FiniteLivedIntangibleAssetsNet_0_Q1_USD":21189000.0,"NumberOfOperatingSegments_1_Q1_segment":1.0,"PreferredStockSharesIssued_0_Q1_shares":0.0,"InventoryNoncurrent_0_Q1_USD":4950000.0,"PropertyPlantAndEquipmentNet_0_Q1_USD":3840000.0,"AvailableForSaleDebtSecuritiesAmortizedCostBasis_0_Q1_USD":305824000.0,"OperatingLeaseRightOfUseAsset_0_Q1_USD":10194000.0,"OtherIncome_1_Q1_USD":87000.0,"StockholdersEquity_0_Q1_USD":467627000.0,"DeferredIncomeTaxAssetsNet_0_Q1_USD":80355000.0,"CommonStockParOrStatedValuePerShare_0_Q1_USD":0.001,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_1_Q1_USD":8.95,"IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_1_Q1_USD":-50000.0,"OtherComprehensiveIncomeLossTax_1_Q1_USD":1000.0,"CommonStockSharesAuthorized_0_Q1_shares":150000000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_1_Q1_USD":62669000.0,"OperatingIncomeLoss_1_Q1_USD":10341000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_1_Q1_USD":10428000.0,"OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax_1_Q1_USD":-47000.0,"AvailableForSaleSecuritiesDebtSecuritiesCurrent_0_Q1_USD":306030000.0,"InventoryNet_0_Q1_USD":1361000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_1_Q1_pure":0.0,"PreferredStockValue_0_Q1_USD":0.0,"DeferredIncomeTaxExpenseBenefit_1_Q1_USD":1160000.0,"LiabilitiesAndStockholdersEquity_0_Q1_USD":543191000.0,"EmployeeRelatedLiabilitiesCurrent_0_Q1_USD":4113000.0,"PreferredStockSharesAuthorized_0_Q1_shares":20000000.0,"AllocatedShareBasedCompensationExpense_1_Q1_USD":3909000.0,"OperatingLeaseLiabilityCurrent_0_Q1_USD":2126000.0,"OtherLiabilitiesNoncurrent_0_Q1_USD":2655000.0,"PaymentsToAcquirePropertyPlantAndEquipment_1_Q1_USD":130000.0,"AccruedProfessionalFeesCurrent_0_Q1_USD":5164000.0,"Ticker":"VNDA","CIK":"1347178","name":"VANDA PHARMACEUTICALS INC.","OfficialName":"Vanda Pharmaceuticals Inc. Common Stock","form":"10-Q","period":"20210331","fy":"2021.0","fp":"Q1","qtrs":"1","uom":"USD","footnote":"nan","Market Cap":"633424667.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20210506"}]